ScoreWhy is Henan Taloph Pharmaceutical Stock Co., Ltd. ?
1
Poor Management Efficiency with a low ROCE of 2.63%
- The company has been able to generate a Return on Capital Employed (avg) of 2.63% signifying low profitability per unit of total capital (equity and debt)
2
High Debt Company with a Debt to Equity ratio (avg) at times
- Poor long term growth as Net Sales has grown by an annual rate of 5.18% and Operating profit at -3.09% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
- The company has been able to generate a Return on Equity (avg) of 1.46% signifying low profitability per unit of shareholders funds
3
Poor long term growth as Net Sales has grown by an annual rate of 5.18% and Operating profit at -3.09% over the last 5 years
4
The company has declared Negative results for the last 3 consecutive quarters
- NET SALES(9M) At CNY 1,186.9 MM has Grown at -11.29%
- INTEREST COVERAGE RATIO(Q) Lowest at 154.13
- INVENTORY TURNOVER RATIO(HY) Lowest at 2.77 times
5
With ROE of 2.58%, it has a very expensive valuation with a 2.27 Price to Book Value
- Over the past year, while the stock has generated a return of 28.12%, its profits have fallen by -63.5%
- At the current price, the company has a high dividend yield of 0.2
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Henan Taloph Pharmaceutical Stock Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Henan Taloph Pharmaceutical Stock Co., Ltd.
21.9%
1.38
39.07%
China Shanghai Composite
21.43%
1.58
14.20%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
4.65%
EBIT Growth (5y)
14.89%
EBIT to Interest (avg)
1.01
Debt to EBITDA (avg)
6.01
Net Debt to Equity (avg)
0.49
Sales to Capital Employed (avg)
0.72
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
2.63%
ROE (avg)
1.46%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
75
Industry P/E
Price to Book Value
2.87
EV to EBIT
44.38
EV to EBITDA
30.90
EV to Capital Employed
2.19
EV to Sales
3.09
PEG Ratio
0.61
Dividend Yield
0.17%
ROCE (Latest)
4.93%
ROE (Latest)
3.80%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Bullish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend7What is working for the Company
NET PROFIT(HY)
At CNY 33.95 MM has Grown at 60.15%
RAW MATERIAL COST(Y)
Fallen by -7.73% (YoY
-19What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at CNY -140.68 MM
INTEREST(Q)
At CNY 13.98 MM has Grown at 13.49%
INTEREST COVERAGE RATIO(Q)
Lowest at 97.3
CASH AND EQV(HY)
Lowest at CNY 505.15 MM
DEBT-EQUITY RATIO
(HY)
Highest at 59.01 %
DEBTORS TURNOVER RATIO(HY)
Lowest at 1.4 times
OPERATING PROFIT(Q)
Lowest at CNY 13.6 MM
OPERATING PROFIT MARGIN(Q)
Lowest at 3.88 %
PRE-TAX PROFIT(Q)
Lowest at CNY 0.77 MM
NET PROFIT(Q)
Lowest at CNY -0.77 MM
Here's what is working for Henan Taloph Pharmaceutical Stock Co., Ltd.
Raw Material Cost
Fallen by -7.73% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Henan Taloph Pharmaceutical Stock Co., Ltd.
Pre-Tax Profit
At CNY 0.77 MM has Fallen at -69.67%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (CNY MM)
Net Profit
At CNY -0.77 MM has Fallen at -155.21%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Interest
At CNY 13.98 MM has Grown at 13.49%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Interest Coverage Ratio
Lowest at 97.3
in the last five periodsMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Operating Cash Flow
Lowest at CNY -140.68 MM
in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (CNY MM)
Operating Profit
Lowest at CNY 13.6 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (CNY MM)
Operating Profit Margin
Lowest at 3.88 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Pre-Tax Profit
Lowest at CNY 0.77 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (CNY MM)
Net Profit
Lowest at CNY -0.77 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (CNY MM)
Cash and Eqv
Lowest at CNY 505.15 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debt-Equity Ratio
Highest at 59.01 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Debtors Turnover Ratio
Lowest at 1.4 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
